Document ID: chunk:federal_register_of_legislation:F2022C00276:clause:1_4:p2
Version: federal_register_of_legislation:F2022C00276
Segment Type: clause
Provision Reference: sch 1 cl 4 (pt 2/2)
Character Range: 6317–7429

following that are collected from a donor for use in the manufacture of an HCT product:
 (a) human cells (including haematopoietic progenitor cells);
 (b) human tissues;
 (c) blood;
 (d) blood components (including plasma).
HCT products means therapeutic goods that comprise, contain or are derived from HCT materials.
HCV means hepatitis C virus.
HIV-1 means human immunodeficiency virus type 1.
HIV-2 means human immunodeficiency virus type 2.
HPC(CB) means haematopoietic progenitor cells obtained from cord blood.
HTLV-1 means human T-lymphotropic virus type 1.
HTLV-2 means human T-lymphotropic virus type 2.
human musculoskeletal tissue includes bone, cartilage, fascia lata, ligament, muscle, and tendon.
in-house IVD medical device has the same meaning as in the MD Regulations.
IVD medical device has the same meaning as in the MD Regulations.
MD Regulations means the Therapeutic Goods (Medical Devices) Regulations 2002.
NAT means nucleic acid amplification testing.
Regulations means the Therapeutic Goods Regulations 1990.
Therapeutic Goods Administration has the same meaning as in the Regulations.